The Biomechanics and Mechanobiology group’s work and Damien Lacroix’s recent ERC grant is the subject of an article in this month’s Teraflop, the magazine of the Centre de Serveis Científics i Acadèmics de Catalunya (CESCA).
The Institute for Bioengineering of Catalonia (IBEC) has been selected to go through to the next phase of the Ministry of Science and Innovation’s ‘Apoyo a Centros y Unidades de Excelencia Severo Ochoa’ programme, it was announced today.
Nanoprobes and Nanoswitches group leader and ICREA professor Pau Gorostiza is featured in an interview in Recercat, the online newsletter of the Commission for Universities and Research of the Ministry of Economy and Knowledge.
An article about BioNanoMed Cat appeared in La Vanguardia’s Dinero supplement on 19 June, in which Josep Samitier and the director general of Biocat, Montserrat Vendrell, explain the aim of the IBEC-led alliance.
Antoni Homs, a postdoc in the Nanobioengineering group, did his bit for the public understanding of science this week by participating in two events in collaboration with the Centre Cultural Sant Josep in Hospitalet.
An article by IBEC associate director Josep Samitier, ‘Nanomedicina: nanotecnologías aplicadas a la salud’ appears in the latest edition of SEBBM, a periodical published by the Sociedad Española de Bioquímica y Biología Molecular.
IBEC group leader Xavier Trepat is the subject of the latest edition of Destacamus, a bimonthly magazine published by Biopol’H which profiles researchers.
In its June edition, El Global, the most prominent journal on the pharmaceutical sector in Spain, features a news item on the IBEC-led alliance BioNanoMed Catalunya, which aims to bring together researchers, hospitals and companies working in nanomedicine.
Angel Raya and his Control of Stem Cell Potency Group appeared in Sunday’s edition of the tres14 program on national TV channel La 2, which this week was devoted to the subject of stem cells.
On Monday 6 June, IBEC will present its activities to biomedical researchers and clinicians from IDIBELL (the Bellvitge Biomedical Research Institute) to kick off an official collaboration agreement between the two institutes.